Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Host molecular target" is a generic classification used in pharmacology and microbiology to describe any endogenous molecule within a host organism—typically a human—that is utilized by a pathogen for its life cycle or targeted by a drug to modulate a physiological process. In the context of infectious diseases, host targets are often proteins such as receptors (e.g., ACE2 for SARS-CoV-2) or enzymes that a virus or bacterium hijacks to enter cells or replicate. In broader drug discovery, it refers to the specific protein, nucleic acid, or other biomolecule that a therapeutic agent binds to in order to produce a clinical effect. Because this term represents a broad category rather than a specific, unique molecular entity, it cannot be assigned specific biological functions, disease roles, or interacting drugs without further clarification of the specific molecule intended.
Not applicable as this is a generic category rather than a specific molecular entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host molecular target.